Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
Clinical trial NCT06427239 · RECRUITING
Trial details
- NCT number
- NCT06427239
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-17
- Primary completion
- 2027-06-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.